产品介绍
戊型病毒性肝炎是一种自愈性传染病,其传播方式、临床表现和预后均与甲型肝炎(甲肝)类似,孕妇患戊肝病死率高为本型肝炎的特点。
|
EV64
|
rAg
|
|
E.coli
|
包被/标记
|
酶免、发光、层析
|
【仅供科学研究使用】
相关产品:
| 产品名称 |
点击数 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, PE|抗人TSHR/LGR3重组抗体,PE标记(靶标:促甲状腺激素受体/富含亮氨酸重复序列G蛋白偶联受体3) |
383 |
| Anti-Human TSHR/LGR3 Recombinant Antibody, PE|抗人TSHR/LGR3重组抗体,PE标记(靶标:促甲状腺激素受体/富含亮氨酸重复序列G蛋白偶联受体3) |
189 |
| Anti-Human CD62E/SELE Recombinant Antibody, PE|抗人CD62E/SELE重组抗体,PE标记(靶标:E-选择素/CD62E) |
473 |
| Anti-Human CD62E/SELE Recombinant Antibody, PE|抗人CD62E/SELE重组抗体,PE标记(靶标:E-选择素/CD62E) |
492 |
| Anti-Human CD62E/SELE Recombinant Antibody, PE|抗人CD62E/SELE重组抗体,PE标记(靶标:E-选择素/CD62E) |
510 |
| Anti-Mouse CD62E/SELE Recombinant Antibody , PE|抗小鼠CD62E/SELE重组抗体,PE标记(靶标:E-选择素/CD62E) |
206 |
| Anti-Human CD36L2 Recombinant Antibody, PE|抗人CD36L2重组抗体,PE标记(靶标:清道夫受体B类成员2/CD36L2) |
454 |
| Anti-Human CD127/IL7R Recombinant Antibody, PE|抗人CD127/IL7R重组抗体,PE标记(靶标:白细胞介素7受体/CD127) |
442 |
| Anti-Human CD127/IL7R Recombinant Antibody, PE|抗人CD127/IL7R重组抗体,PE标记(靶标:白细胞介素7受体/CD127) |
276 |
| Anti-Human CD127/IL7R Recombinant Antibody, PE|抗人CD127/IL7R重组抗体,PE标记(靶标:白细胞介素7受体/CD127) |
308 |
| Anti-Human IFNAR1 Recombinant Antibody , PE|抗人IFNAR1重组抗体,PE标记(靶标:干扰素α/β受体1) |
205 |
| Anti-Mouse IFNAR1 Recombinant Antibody, PE|抗小鼠IFNAR1重组抗体,PE标记(靶标:干扰素α/β受体1) |
336 |
| Anti-Human CD49b/ITGA2 Recombinant Antibody , PE|抗人CD49b/ITGA2重组抗体,PE标记(靶标:整合素α2亚基/CD49b) |
163 |
| Anti-Human CD105/ENG Recombinant Antibody , PE|抗人CD105/ENG重组抗体,PE标记(靶标:内皮素/CD105) |
447 |
| Anti-Human CD35/CR1 Recombinant Antibody, PE|抗人CD35/CR1重组抗体,PE标记(靶标:补体受体1/CD35) |
473 |
| Anti-Mouse CD35/CR1/CD21b Recombinant Antibody, PE|抗小鼠CD35/CR1/CD21b重组抗体,PE标记(靶标:补体受体1/CD35) |
488 |
| Anti-Mouse CD35/CR1/CD21b Recombinant Antibody, PE|抗小鼠CD35/CR1/CD21b重组抗体,PE标记(靶标:补体受体1/CD35) |
142 |
| Anti-Mouse LGALS3 Recombinant Antibody, PE|抗小鼠LGALS3重组抗体,PE标记(靶标:半乳糖凝集素3) |
271 |
| Anti-Human FLT1/ VEGFR1 Recombinant Antibody , PE|抗人FLT1/VEGFR1重组抗体,PE标记(靶标:Fms相关酪氨酸激酶1/血管内皮生长因子受体1) |
376 |
| Anti-Mouse FLT1/VEGFR1 Recombinant Antibody, PE|抗小鼠FLT1/VEGFR1重组抗体,PE标记(靶标:Fms相关酪氨酸激酶1/血管内皮生长因子受体1) |
226 |